Measles Yesterday, Today & Tomorrow

Following is a short summary of a longer special report “What Is Going On With Measles? The Science and Politics of Eradicating Measles” that can be read on NVIC’s website here. This year, the fear mongering about measles has reached epidemic proportions in America. A day doesn’t go by without media outlets publishing angry articles […]
Children in Two States Get Vaccine Strain Measles from MMR Vaccine

Media sources in Michigan reported in April 2019 that two children in the state who were believed to have measles turned out not to have disease, after all. Genotype lab testing of the measles virus identified in the children’s blood was conducted and it was found to match the attenuated (weakened) vaccine strain measles virus […]
MMR Vaccine Offered to Fans at Indianapolis 500 Race

Fans attending the 103rd running of the Indianapolis 500 car race in Indianapolis, Indiana on May 26, 2019 were offered the MMR (measles, mumps and rubella) vaccine at the track’s medical center.1 Prior to the start of the race, which was attended by more than 250,000 people, IndyCar medical director Geoffery Billows, MD of Indiana […]
Toddler in China Dies Day After Rabies Vaccination

A three-year-old girl in China died last month shortly after receiving a rabies vaccine. According to a report from the South China Morning Post, the child was taken by her father to a hospital the city of Lianyungang after being scratched on the finger by a pet dog. She was vaccinated about 23 hours later.1 […]
Unintended Consequences: Dirty Genes in Vaccines

What happens when our government regulatory agencies tasked with protecting the public’s health fails to disclose the risks known by the industry? In the case of viruses and DNA in vaccines, the U.S. Food and Drug Administration (FDA) has internally noted1 that “small amounts of residual cell substrate DNA unavoidably occur in all viral vaccines […]
FDA Licenses Dengvaxia Vaccine After Students Die in Philippines

The U.S. Food and Drug Administration (FDA) announced on May 1, 2019 its licensing approval of Sanofi Pasteur’s Dengvaxia vaccine, which was designed to prevent a mosquito borne viral infection known as dengue fever.1 Symptoms of dengue range from mild (or none at all) to high fever along with headache, body pain, nausea, vomiting and […]
